Cargando…

Comparison of 1.1 GBq and 2.2 GBq Activities in Patients with Low-Risk Differentiated Thyroid Cancer Requiring Postoperative (131)I Administration: A Real Life Study

SIMPLE SUMMARY: The aim of the present study was to retrospectively evaluate the efficacy of low (1.1 GBq) versus moderate (2.2 GBq) (131)I activities in a large series (n = 299) of low-risk differentiated thyroid carcinoma (DTC) patients requiring postoperative (131)I ablation. At the follow-up, ac...

Descripción completa

Detalles Bibliográficos
Autores principales:	Campennì, Alfredo, Ruggeri, Rosaria Maddalena, Garo, Maria Luisa, Siracusa, Massimiliano, Restuccia, Giovanna, Rappazzo, Andrea, Rosarno, Helena, Nicocia, Antonio, Cardile, Davide, Ovčariček, Petra Petranović, Baldari, Sergio, Giovanella, Luca
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10177573/ https://www.ncbi.nlm.nih.gov/pubmed/37173884 http://dx.doi.org/10.3390/cancers15092416

Ejemplares similares

Thyroid Hormone Withdrawal versus Recombinant Human TSH as Preparation for I-131 Therapy in Patients with Metastatic Thyroid Cancer: A Systematic Review and Meta-Analysis
por: Giovanella, Luca, et al.
Publicado: (2023)

Multi-GBq production of the radiotracer [(18)F]fallypride in a droplet microreactor
por: Wang, Jia, et al.
Publicado: (2020)

Thyroglobulin Value Predict Iodine-123 Imaging Result in Differentiated Thyroid Cancer Patients
por: Campennì, Alfredo, et al.
Publicado: (2023)

Star-Shaped Intense Uptake of (131)I on Whole Body Scans Can Reflect Good Therapeutic Effects of Low-Dose Radioactive Iodine Treatment of 1.1 GBq
por: Kong, Sung Hye, et al.
Publicado: (2018)

Optimization of Deuteron Irradiation of (176)Yb for Producing (177)Lu of High Specific Activity Exceeding 3000 GBq/mg
por: Shao, Lin
Publicado: (2023)

Prevalence of thyroid dysfunction in patients with COVID-19: a systematic review
por: Giovanella, Luca, et al.
Publicado: (2021)

Accuracy of papillary thyroid cancer prognostic nomograms: a systematic review
por: Luisa Garo, Maria, et al.
Publicado: (2023)

A long-term retrospective cohort-based risk-benefit analysis of augmenting total cumulative I-131 activity to 37GBq in differentiated thyroid cancer patients with skeletal metastases
por: Kanankulam Velliangiri, Sivasankar, et al.
Publicado: (2023)

Thyroid Cancer Persistence in Patients with Unreliable Thyroglobulin Measurement: Circulating microRNA as Candidate Alternative Biomarkers
por: Campennì, Alfredo, et al.
Publicado: (2022)

Molecular Imaging and Theragnostics of Thyroid Cancers
por: Giovanella, Luca, et al.
Publicado: (2022)

Subacute thyroiditis in a patient infected with SARS-COV-2: an endocrine complication linked to the COVID-19 pandemic
por: Ruggeri, Rosaria Maddalena, et al.
Publicado: (2020)

Differentiating malignant from benign thyroid nodules with indeterminate cytology by (99m)Tc-MIBI scan: a new quantitative method for improving diagnostic accuracy
por: Campennì, A., et al.
Publicado: (2017)

Hepatocyte Growth Factor/C-Met Axis in Thyroid Cancer: From Diagnostic Biomarker to Therapeutic Target
por: Trovato, Maria, et al.
Publicado: (2017)

Otto: a 4.04 GBq (109 mCi) (68)Ge/(68)Ga generator, first of its kind - extended quality control and performance evaluation in the clinical production of [(68)Ga]Ga-PSMA-11
por: Waterhouse, Nicole N., et al.
Publicado: (2020)

HER2 Analysis in Sporadic Thyroid Cancer of Follicular Cell Origin
por: Ruggeri, Rosaria M., et al.
Publicado: (2016)

Molecular Theranostics in Radioiodine-Refractory Differentiated Thyroid Cancer
por: Petranović Ovčariček, Petra, et al.
Publicado: (2023)

The EANM guideline on radioiodine therapy of benign thyroid disease
por: Campennì, Alfredo, et al.
Publicado: (2023)

The Influence of Food Regimes on Oxidative Stress: A Permutation-Based Approach Using the NPC Test
por: Zirilli, Agata, et al.
Publicado: (2023)

What is New on Thyroid Cancer Biomarkers
por: Ruggeri, Rosaria M., et al.
Publicado: (2008)

Undetectable or low (<1 ng/ml) postsurgical thyroglobulin values do not rule out metastases in early stage differentiated thyroid cancer patients
por: Campennì, Alfredo, et al.
Publicado: (2018)

Postoperative thyroglobulin as a yard-stick for radioiodine therapy: decision tree analysis in a European multicenter series of 1317 patients with differentiated thyroid cancer
por: Giovanella, Luca, et al.
Publicado: (2023)

New! F-18-based PET/CT for sodium-iodine-symporter-targeted imaging!
por: Verburg, Frederik A., et al.
Publicado: (2020)

1′-Methyl-4′-phenyldispiro[indan-2,2′-pyrrolidine-3′,2′′-indan]-1,3,1′′-trione
por: Wei, Ang Chee, et al.
Publicado: (2011)

Coexistence of diffuse large B-cell lymphoma and papillary thyroid carcinoma in a patient affected by Hashimoto's thyroiditis
por: Trovato, Maria, et al.
Publicado: (2017)

The EANM practice guidelines for parathyroid imaging
por: Petranović Ovčariček, Petra, et al.
Publicado: (2021)

4′-(4-Chlorophenyl)-1′-methyldispiro[indan-2,2′-pyrrolidine-3′,2′′-indan]-1,3,1′′-trione
por: Wei, Ang Chee, et al.
Publicado: (2011)

Commentary: L-T4 Therapy in Enteric Malabsorptive Disorders
por: Giuffrida, Giuseppe, et al.
Publicado: (2021)

Autoimmune Thyroid Disorders: The Mediterranean Diet as a Protective Choice
por: Ruggeri, Rosaria Maddalena, et al.
Publicado: (2023)

Supra-Acetabular Brown Tumor due to Primary Hyperparathyroidism Associated with Chronic Renal Failure
por: Ruggeri, Rosaria M., et al.
Publicado: (2010)

SARS-CoV-2 vaccine may trigger thyroid autoimmunity: real-life experience and review of the literature
por: Ruggeri, R. M., et al.
Publicado: (2022)

4′-(4-Bromophenyl)-1′-methyldispiro[indan-2,2′-pyrrolidine-3′,2′′-indan]-1,3,1′′-trione
por: Wei, Ang Chee, et al.
Publicado: (2011)

4′-(3-Bromophenyl)-1′-methyldispiro[indan-2,2′-pyrrolidine-3′,2′′-indan]-1,3,1′′-trione
por: Wei, Ang Chee, et al.
Publicado: (2012)

Immunohistochemical localization and functional characterization of somatostatin receptor subtypes in a corticotropin releasing hormone-secreting adrenal phaeochromocytoma: review of the literature and report of a case
por: Ruggeri, R.M., et al.
Publicado: (2009)

Analysis of ACE2 genetic variants in 131 Italian SARS-CoV-2-positive patients
por: Novelli, Antonio, et al.
Publicado: (2020)

Personalized management of differentiated thyroid cancer in real life – practical guidance from a multidisciplinary panel of experts
por: Campennì, Alfredo, et al.
Publicado: (2020)

1′-Methyl-4′-[4-(trifluoromethyl)phenyl]dispiro[indan-2,2′-pyrrolidine-3′,2′′-indan]-1,3,1′′-trione
por: Wei, Ang Chee, et al.
Publicado: (2011)

4′-(4-Fluorophenyl)-1′-methyldispiro[indane-2,2′-pyrrolidine-3′,2′′-indane]-1,3,1′′-trione methanol hemisolvate
por: Ali, Mohamed Ashraf, et al.
Publicado: (2013)

PRIMARY HYPERPARATHYROIDISM AND SERUM CALCIUM IN BREAST CANCER PATIENTS EVALUATED FOR LOW BONE MASS – A SINGLE CENTER EXPERIENCE
por: Punda, Marija, et al.
Publicado: (2021)

4′-[5-(4-Fluorophenyl)pyridin-3-yl]-1′-methyldispiro[indan-2,2′-pyrrolidine-3′,2′′-indan]-1,3,1′′-trione
por: Wei, Ang Chee, et al.
Publicado: (2011)

The role of thyroglobulin doubling time in differentiated thyroid cancer: a meta-analysis
por: Giovanella, Luca, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_a13a11qbbqfr6g4409ft0f661g